The Brief
- A new $22.4 million federal grant will allow Moffitt Cancer Center to study a rare and often deadly condition that affects cancer patients.
- Researchers at Moffitt will work to research and develop treatment for leptomeningeal disease through two clinical trials over the next four to six years.
TAMPA, Fla. – A new federal grant is allowing Moffitt Cancer Center to study a rare and aggressive disease that affects cancer patients, and doctors hope the results will give them the chance for a longer life.
The backstory:
Every day is a gift for Heather Curley, and Thursday marked a special milestone for her. She is able to share smiles with her doctor at Moffitt Cancer Center after she was diagnosed with an extremely rare disease that only affects 3-5% of women like her.…